We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Novel Blood Biomarker Identified for Autism

By LabMedica International staff writers
Posted on 17 May 2016
Print article
Image: On-bead magnetic screening for autism spectrum disorder blood biomarkers (Photo courtesy of UT Southwestern Medical Center).
Image: On-bead magnetic screening for autism spectrum disorder blood biomarkers (Photo courtesy of UT Southwestern Medical Center).
Early intervention is the key to the best treatment for autism spectrum disorder (ASD), which affects about 1 in 70 children. Unfortunately, most children are not diagnosed until about age four, when communication and social disabilities become apparent.

Blood biomarkers have been identified that could distinguish the majority of ASD study participants versus a control group of similar age range. In addition, the biomarker was significantly correlated with the level of communication impairment, suggesting that the blood test may give insight into ASD severity.

Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) recruited for an ASD group 74 male subjects with a median age of 5.6 years; 60 males with a median age of 6.3years for a typically developing group (TD), 10 ASD females and 20 TD females. For a control group 53 adult male serum samples were obtained whose median age was 69 years. A fasting blood draw was performed on all ASD and TD subjects.

Since other studies have found abnormalities in the immune systems of autistic children, the scientists set out to search for antibodies in the blood related to ASD. The teams used various techniques to isolate biomarkers. These included peptoid library synthesis, on-bead magnetic screening, peptoid enzyme-linked immunosorbent assay (ELISA), affinity purification of peptoid-binding proteins, gel electrophoresis and Coomassie Blue staining.

The investigators found that found that boys with ASD had significantly reduced levels of a serum immunoglobulin G1 (IgG1) antibody. Investigating further, they analyzed 25 peptoid compounds that bound to IgG1 and zeroed in on one, ASD1, that was 66% accurate in diagnosing ASD. When combined with thyroid stimulating hormone level measurements, the ASD1-binding biomarker was 73% accurate at diagnosis. Girls made up a small ratio of the study group, and the biomarker did not correlate as strongly with ASD diagnosis as with boys.

Dwight German, PhD, a Professor of Psychiatry and senior author of the study said, “Numerous investigators have long sought a biomarker for ASD. The blood biomarker reported here along with others we are testing can represent a useful test with over 80% accuracy in identifying ASD.” The study was published in the June 2016 issue of the journal Scientific Reports.

Related Links:
University of Texas Southwestern Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.